INC buys Trident to expand in Phase I and Asia Pacific
INC Research is continuing its acquisition driven growth strategy by buying APAC-focused CRO Trident Clinical Research.
INC Research is continuing its acquisition driven growth strategy by buying APAC-focused CRO Trident Clinical Research.
Parexel CEO Josef von Rickenbach predicts more Big Pharma strategic partnerships.
Pfizer says it is considering a manufacturing-focused partnership with China’s Zhejiang Hisun Pharmaceutical as part of its generic drug business.
Biomanufacturing technology firm Xcellerex has had a good start to June with R-Pharm and Fujifilm Diosynth signing up as customers.
US-based Aptiv Solutions, a new adaptive clinical trial-focused contract research organisation (CRO), officially began operations today.